Editorial Board
Christoph-Thomas Germer, Ingo Hartlapp, Christian Doehn(University of Lübeck), Jan Janßen, Baogui Wang(Tianjin Medical University Cancer Institute and Hospital), Hans‐Peter Lipp(University of Zurich), W.F. Mourad(Mount Sinai Beth Israel), Manfred Kindler(Praxis), Hermann Einsele(Universitätsklinikum Würzburg), Maike de Wit(Florida Hospital Cancer Institute), Thomas Steiner(Helios Klinikum Erfurt), Dan Ishihara(Albert Einstein College of Medicine), R.A. Shourbaji, Friedrich Overkamp, Andreas Jakob(Offenburg University of Applied Sciences), Hongjie Zhan, Dukagjin Blakaj(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Lothar Bergmann(Universität Ulm), Markus Ruhnke(Radboud University Nijmegen), Volker Kunzmann(University of Würzburg), Joerg Schmitz(Springer Nature (Germany)), Petra Ortner, Zhen Chen, Carsten Bokemeyer(Universität Hamburg), Ulrich Kube(Goethe Institut), Peter J. Goebell(Friedrich-Alexander-Universität Erlangen-Nürnberg), Gernot Guderian(University of Basel), Michael Staehler(München Klinik), Xiangyu Liu, Mahesh Kumar(European Society for Blood and Marrow Transplantation), Han Liang(First Affiliated Hospital of Zhengzhou University), Huili Zhu(Yantai University), Junhua Lin, Kenneth S. Hu(Mount Sinai Beth Israel), Karin Jordan(Martin Luther University Halle-Wittenberg), Zhiqiang Meng(Shanghai Medical College of Fudan University), Edwin Herrmann(St. Jude Children's Research Hospital), Gabriel Steiner, Michael Albrecht(Novartis (Germany)), Huifeng Gao, Regine Mayer-Steinacker, Xishan Hao(Tianjin Medical University Cancer Institute and Hospital), Louis B. Harrison(St. Luke's-Roosevelt Hospital Center), Jingyu Deng(Tianjin Medical University Cancer Institute and Hospital), Yehua Shen(Shanghai Medical College of Fudan University), Steffen Weikert(St. Hedwig-Krankenhaus), Wilson Lin, Jalid Sehouli(Charité - Universitätsmedizin Berlin), Kun Wang(People's Liberation Army 401 Hospital), Michael Untch(Helios Kliniken)
Cited by 0
Related Papers
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
|Clinical Infectious Diseases|2008|4.9k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
|Cell|2014|2.5k
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
|Annals of Internal Medicine|2020|2.4k